Possible enhancement of Epstein-Barr virus infections by the use of OKT3 in transplant recipients.
Ren
E C
EC
Department of Microbiology, Faculty of Medicine, National University of Singapore.
Chan
S H
SH
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology*; D001402:B-Lymphocytes / Q000382:microbiology; D017252:CD3 Complex; D002478:Cells, Cultured; D006566:Herpesviridae Infections / Q000276:immunology*; D004854:Herpesvirus 4, Human / Q000254:growth & development; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D009894:Opportunistic Infections / Q000276:immunology*; D011948:Receptors, Antigen, T-Cell / Q000276:immunology*
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D017252:CD3 Complex; D011948:Receptors, Antigen, T-Cell